These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22497075)

  • 1. [Synthesis of low molecular weight mimetics of heparin].
    Krylov VB; Ustiuzhanina NE; Nifant'ev NE
    Bioorg Khim; 2011; 37(6):745-79. PubMed ID: 22497075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of antithrombotic polysaccharide derivatives.
    Franz G; Alban S
    Int J Biol Macromol; 1995 Dec; 17(6):311-4. PubMed ID: 8789331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin.
    Kuberan B; Beeler DL; Lawrence R; Lech M; Rosenberg RD
    J Am Chem Soc; 2003 Oct; 125(41):12424-5. PubMed ID: 14531682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial synthetic glucan sulfates as potential new antithrombotics: a review.
    Alban S; Franz G
    Biomacromolecules; 2001; 2(2):354-61. PubMed ID: 11749192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dracula's wish.
    Peters R; Sikorski R
    Science; 1999 May; 284(5418):1294. PubMed ID: 10383310
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin mimetics with anticoagulant activity.
    Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Ferro V
    Med Res Rev; 2018 Sep; 38(5):1582-1613. PubMed ID: 29446104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides.
    Miller GJ; Broberg KR; Rudd C; Helliwell MR; Jayson GC; Gardiner JM
    Org Biomol Chem; 2015 Dec; 13(46):11208-19. PubMed ID: 26381107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea.
    Groth I; Grünewald N; Alban S
    Glycobiology; 2009 Apr; 19(4):408-17. PubMed ID: 19106233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin.
    Herczeg M; Lázár L; Bereczky Z; Kövér KE; Timári I; Kappelmayer J; Lipták A; Antus S; Borbás A
    Chemistry; 2012 Aug; 18(34):10643-52. PubMed ID: 22782535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant Properties of a Green Algal Rhamnan-type Sulfated Polysaccharide and Its Low-molecular-weight Fragments Prepared by Mild Acid Degradation.
    Liu X; Du P; Liu X; Cao S; Qin L; He M; He X; Mao W
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30424528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of "neoheparin" from E. coli K5 capsular polysaccharide.
    Lindahl U; Li JP; Kusche-Gullberg M; Salmivirta M; Alaranta S; Veromaa T; Emeis J; Roberts I; Taylor C; Oreste P; Zoppetti G; Naggi A; Torri G; Casu B
    J Med Chem; 2005 Jan; 48(2):349-52. PubMed ID: 15658847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate.
    Alban S; Jeske W; Welzel D; Franz G; Fareed J
    Thromb Res; 1995 May; 78(3):201-10. PubMed ID: 7631300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
    Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
    Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.
    Petitou M; Lormeau JC; Choay J
    Nature; 1991 Apr; 350(6319 Suppl):30-3. PubMed ID: 2017262
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives.
    Mourão PA
    Curr Pharm Des; 2004; 10(9):967-81. PubMed ID: 15078127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the heparin-based anticoagulant drug fondaparinux.
    Chang CH; Lico LS; Huang TY; Lin SY; Chang CL; Arco SD; Hung SC
    Angew Chem Int Ed Engl; 2014 Sep; 53(37):9876-9. PubMed ID: 25044485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity.
    Pomin VH; Pereira MS; Valente AP; Tollefsen DM; Pavão MS; Mourão PA
    Glycobiology; 2005 Apr; 15(4):369-81. PubMed ID: 15590773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
    Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
    J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.